Mechanism for monitoring deterioration degree of DAB immunohistochemical staining solution
By integrating light source and scattered light monitoring device in the DAB dye solution preparation container, the scattered signal of the dye solution is monitored, and the problem of poor stability of DAB dye is solved, and a large amount of DAB dye is prepared at one time is improved, fully automatic immunohistochemistry is improved The operation efficiency and dyeing effect of the dyeing machine.
Patent Information
- Application Number
- CN202411015094.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-15
AI Technical Summary
In the prior art, the DAB immunohistochemical dye has poor stability, which causes impurities to enter the dyeing system after deterioration, affecting the dyeing effect, and lacks effective quality detection methods, which limits the amount of dyeing solution preparation of the fully automatic immunohistochemical dyeing machine, and increases the Workload and dyeing cycle.
A mechanism for monitoring the deterioration of DAB immunohistochemical staining solution is designed, including a DAB staining solution preparation container, light source, mixing device and scattered light monitoring device. The scattered signal of the staining solution is monitored through optical detection to ensure the freshness of the staining solution. , realize the preparation of a large amount of DAB dye at one time.
It effectively improves the operating efficiency of the fully automatic immunohistochemical staining machine, avoids the use of spoiled dyeing agents, and ensures the stability of the dyeing effect and the timeliness of diagnosis.
Smart Images

Figure CN118961579A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biochemical technology, and more particularly to a mechanism for monitoring the deterioration degree of DAB immunohistochemical staining solution. Background Art
[0002] Immunohistochemistry mainly utilizes the high specificity of the binding between antibodies and antigens, that is, certain chemical substances in tissues or cells are first extracted, and used as antigens or haptens to immunize experimental animals such as mice to prepare specific antibodies, and then this antibody (first antibody) is used as an antigen to immunize animals to prepare second antibodies, and then treated with a certain enzyme (commonly used horseradish peroxidase) or biotin, etc., and then combined with the aforementioned antigen components to amplify the antigen. Since the immune complex formed after the antibody and antigen are combined is colorless, it is also necessary to use histochemical methods to display the antigen-antibody reaction site (the commonly used color developer DAB is displayed as brown-yellow particles). Through antigen-antibody reaction and color reaction, the chemical components in cells or tissues are displayed. The antigen-antibody reaction products occurring in the cells can be clearly seen under a microscope, so that the distribution and content of certain chemical components can be determined in situ in cells or tissues. Any substance in tissues or cells that can be used as an antigen or hapten, such as proteins, polypeptides, amino acids, polysaccharides, phospholipids, receptors, enzymes, hormones, nucleic acids and pathogens, can be detected with corresponding specific antibodies.
[0003] DAB (diaminobenzidine) dye is composed of two parts, one bottle is DAB (diaminobenzidine) solution, and the other bottle is hydrogen peroxide solution. When using, DAB (diaminobenzidine) solution and hydrogen peroxide solution are prepared.
[0004] Since the prepared DAB (diaminobenzidine) dye has poor stability, it will deteriorate and precipitate after a period of time. If the deteriorated dye is used for staining, impurities will be brought into the reaction system, affecting the staining effect of the tissue section and causing non-specific staining.
[0005] To solve this problem, the usual practice of the fully automatic immunohistochemical staining machine is that before using the DAB (diaminobenzidine) stain, the instrument uses a sample needle to aspirate the DAB (diaminobenzidine) solution and hydrogen peroxide solution, and prepares them temporarily. After the staining process reaches the staining step, the staining solution is added to the reaction system.
[0006] Since it is impossible to confirm how long the remaining amount of the used staining solution will remain stable, it is necessary to promptly remove the remaining solution in the preparation chamber with a sample needle so that it can be temporarily prepared when the staining solution is needed in the next round of staining.
[0007] If a large amount of staining solution is prepared at one time, there is no guarantee as to when the next round of experiments will be carried out, and whether the DAB staining solution has deteriorated when used in the next round of experiments. Therefore, due to the lack of effective quality inspection and monitoring methods for DAB staining solution, the fully automatic immunohistochemistry staining machine cannot prepare a large amount of staining solution at one time to avoid the risk of abnormal staining.
[0008] The disadvantage of doing so is that multiple preparations of DAB (diaminobenzidine) stain increase the workload of the pipette needle, which takes up the cycle of adding relevant reagents in the staining process, thereby lengthening the staining cycle. The staining cycle and the time it takes for clinical institutions to issue pathology reports are both factors that have a significant impact on the timeliness of clinical diagnosis. Summary of the invention
[0009] The purpose of the present invention is to provide a mechanism for monitoring the degree of deterioration of DAB immunohistochemical staining solution in the staining process, which can realize the preparation of a large amount of DAB staining agent at one time, effectively improve the operating efficiency of the fully automatic immunohistochemical staining machine, and avoid the deterioration of the staining machine being used in the staining process.
[0010] A mechanism for monitoring the degree of deterioration of a DAB immunohistochemical staining solution comprises a DAB staining solution preparation container, a light source is provided on one side of the DAB staining solution preparation container, a mixing device is provided below the DAB staining solution preparation container for vibrating the solution, and a scattered light monitoring device for the emitted light is provided on the other side of the DAB staining solution preparation container. The mechanism for monitoring the degree of deterioration of a DAB immunohistochemical staining solution can prepare a large amount of DAB staining agent at one time, effectively improve the operating efficiency of a fully automatic immunohistochemical staining machine, and prevent a staining machine that has deteriorated from being used in the staining process.
[0011] As a further improvement and supplement to the above solution, the present invention also includes the following additional technical features:
[0012] The light source is a laser light source or a combination of an LED light source and a convex lens.
[0013] The light source comprises:
[0014] The first socket, voltage stabilizing chip and output voltage provide stable power supply for the light source and ensure voltage balance;
[0015] A laser, a variable resistor RP1 for balancing the voltage inside the laser, a first transistor Q1 and a second transistor Q2 for providing a driving current for the laser;
[0016] The scattered light monitoring device comprises:
[0017] A second socket for providing power and a supply voltage for providing a filtered and stabilized voltage;
[0018] The current-to-voltage converter, voltage follower and analog-to-digital converter amplify and convert the current into voltage, and convert the voltage into a digital signal for output.
[0019] The structure is reasonable and the control is effective to ensure the accuracy of digital output.
[0020] The mixing device is fixed on a fixing seat with a rubber fixing column, and the mixing device is a high-frequency DC vibration flat motor, which ensures that the mixed liquid is evenly mixed.
[0021] The DAB dyeing solution preparation container is made of organic glass, which has good transmission performance and corrosion resistance.
[0022] The method for monitoring the degree of deterioration of the DAB immunohistochemical staining solution comprises the following steps:
[0023] Step 1, prepare DAB staining solution, which includes: DAB concentrate - color developing solution A, DAB diluent - containing H2O2, color developing solution B and color developing solution A at a ratio of 1:20, and mix well;
[0024] Step 2, start the light source so that the focus of the light is focused on the center of the DAB dye solution preparation container 3;
[0025] Step 3: Start high-frequency vibration, mix the DAB staining solution and keep it still for more than 10 seconds;
[0026] Step 4, starting optical detection, monitoring the scattered signal, and detecting the light value of the scattered light;
[0027] In step four,
[0028] The laboratory established a standard value S0 for the scattering signal of fresh DAB staining solution;
[0029] Establish the scattering signal change △S of the DAB dye solution just after deterioration;
[0030] During the operation of the instrument, when a new round of experiments is carried out, the scattering signal S1 of the DAB dye solution is monitored in advance, and S0 is subtracted from S1 to obtain △S1;
[0031] When △S1 is greater than △S, the staining solution is considered to have deteriorated, and the instrument drains the deteriorated staining solution in the container and re-prepares fresh DAB staining solution online;
[0032] When △S1 is less than △S, the dyeing solution is considered to be not deteriorated and the current round of tests can continue to be used.
[0033] When a new round of experiments is about to begin, the prepared DAB staining solution can be tested again to see if it has deteriorated.
[0034] The invention discloses a method for effectively monitoring whether a DAB stain has deteriorated. Thus, a large amount of DAB (diaminobenzidine) stain can be prepared at one time, and the operation efficiency of the fully automatic immunohistochemical staining machine can be effectively improved.
[0035] The following beneficial effects can be achieved by using the present invention: the present invention can effectively monitor whether the DAB (diaminobenzidine) dye is deteriorated. Thus, a large amount of DAB (diaminobenzidine) dye can be prepared at one time, effectively improving the operating efficiency of the fully automatic immunohistochemical staining machine, and avoiding the use of a deteriorated dyeing machine in the dyeing process. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 It is a structural schematic diagram of the present invention.
[0037] Figure 2 It is the voltage output circuit in the scattered light monitoring device 5 of the present invention.
[0038] Figure 3 It is the power supply voltage stabilizing driving circuit in the scattered light monitoring device 5 of the present invention.
[0039] Figure 4 It is the power supply output circuit in the scattered light monitoring device 5 of the present invention.
[0040] Figure 5 It is the signal processing circuit of the scattered light receiving end in the scattered light monitoring device 5 of the present invention. DETAILED DESCRIPTION
[0041] The specific embodiments of the present invention are described in detail below with reference to the accompanying drawings.
[0042] like Figure 1-5 As shown, the present invention is a mechanism for monitoring the degree of deterioration of DAB immunohistochemical staining solution.
[0043] The mechanism for monitoring the deterioration degree of the DAB immunohistochemical staining solution described in this embodiment includes a DAB staining solution preparation container 3, a light source 1 is provided on one side of the DAB staining solution preparation container 3, and a mixing device 4 is provided below the DAB staining solution preparation container 3 for vibrating the solution; a scattered light monitoring device 5 for the emitted light is provided on the other side of the DAB staining solution preparation container 3.
[0044] Furthermore, the light source 1 is a combination of a laser light source or an LED light source and a convex lens.
[0045] Further,
[0046] The light source 1 comprises:
[0047] The first socket 6, the voltage stabilizing chip 7 and the output voltage 8 provide a stable power supply for the light source 1 to ensure a balanced supply voltage; in this embodiment, the output voltage is 3.3VA.
[0048] Laser 9, a variable resistor RP111 for balancing the internal voltage of the laser, a first transistor Q112 and a second transistor Q210 for providing driving current to the laser 9; the switching state of the second transistor Q2 is controlled by the first transistor Q1, and the second transistor Q2 controls the magnitude of the laser light source current.
[0049] The scattered light monitoring device 5 comprises:
[0050] A second socket 13 for providing power and a power supply voltage 14 for providing a filtered stable voltage; in this embodiment, the voltage is 5V, which provide voltages for a voltage follower 16 and an analog-to-digital converter 17 respectively.
[0051] The current-to-voltage converter 15, voltage follower 16 and analog-to-digital converter 17 amplify and convert the current into a voltage, and convert the voltage into a digital signal for output.
[0052] After power is turned on, the laser 9 lights up, and the light source irradiates the DAB dye solution preparation container 3 through DAB scattered light, generating a scattered color signal. The scattered color signal shines on the photodiode, generating an induced current. The induced current is converted into a digital signal through the amplified voltage, and the digital signal is transmitted to the single-chip microcomputer for numerical output.
[0053] Furthermore, the mixing device 4 is fixed on the fixing base 2 with a rubber fixing column, and the mixing device 4 is a high-frequency vibration DC vibration flat motor.
[0054] Furthermore, the DAB dye solution preparation container 3 is made of organic glass.
[0055] The method for monitoring the degree of deterioration of the DAB immunohistochemical staining solution comprises the following steps:
[0056] Step 1, prepare DAB staining solution, which includes: DAB concentrate - color developing solution A, DAB diluent - containing H2O2, color developing solution B and color developing solution A at a ratio of 1:20, and mix well;
[0057] Step 2, start the light source so that the focus of the light is focused on the center of the DAB dye solution preparation container 3;
[0058] Step 3: Start high-frequency vibration, mix the DAB staining solution and keep it still for more than 10 seconds;
[0059] Step 4, starting optical detection, monitoring the scattered signal, and detecting the light value of the scattered light;
[0060] In step four,
[0061] The laboratory established a standard value S0 for the scattering signal of fresh DAB staining solution;
[0062] Establish the scattering signal change △S of the DAB dye solution just after deterioration;
[0063] During the operation of the instrument, when a new round of experiments is carried out, the scattering signal S1 of the DAB dye solution is monitored in advance, and S0 is subtracted from S1 to obtain △S1;
[0064] When △S1 is greater than △S, the staining solution is considered to have deteriorated, and the instrument drains the deteriorated staining solution in the container and re-prepares fresh DAB staining solution online;
[0065] When △S1 is less than △S, the dyeing solution is considered to be not deteriorated and the current round of tests can continue to be used.
[0066] When a new round of experiments is about to begin, the prepared DAB staining solution can be tested again to see if it has deteriorated.
[0067] In step 1, prepare DAB staining solution, which includes: DAB concentrate - color developing solution A, DAB diluent - containing H2O2, color developing solution B and color developing solution A are 1:20, that is, take 1ml color developing solution B, add 50ul color developing solution A, and mix well;
[0068] When △S1 is less than △S, the dyeing solution is considered to be not deteriorated and the current round of tests can continue to be used.
[0069] When a new round of experiments is about to begin, the prepared DAB staining solution can be tested again to see if it has deteriorated.
[0070] Method for establishing standard values S0 and △S:
[0071] Preparation method of DAB staining solution:
[0072] Reagents and materials:
[0073] DAB (diaminobezidin 3,3'-diaminobenzidine) powder
[0074] Tris-HCl buffer (pH 7.6, 10 mM): used to adjust the pH value of the DAB solution.
[0075] NiCl2 or CoCl2 (0.3% W / V): as catalyst.
[0076] 30% H2O2: acts as an oxidizing agent.
[0077] Distilled water: used to prepare solutions.
[0078] 3. Preparation steps
[0079] Preparation before solution preparation:
[0080] Ensure that the laboratory environment is clean and tidy and meets the requirements of sterile operation.
[0081] Prepare the necessary reagents and materials and check their expiration dates and labels.
[0082] Preparation of Tris-HCl buffer (10 mM, pH 7.6):
[0083] Accurately weigh Tris-HCl powder, add it to distilled water, and stir until it is completely dissolved.
[0084] The pH of the solution was adjusted to 7.6 using a pH meter.
[0085] Make up to the required volume, mix and set aside.
[0086] Preparation of DAB solution:
[0087] In a clean, dry container, add an appropriate amount of Tris-HCl buffer (e.g. 9 mL).
[0088] Accurately weigh DAB powder, add it to the buffer, and stir until completely dissolved.
[0089] Add 1 mL of 0.3% W / V NiCl2 or CoCl2 solution and continue stirring evenly.
[0090] Preparation of DAB color development working solution:
[0091] Add an appropriate amount of 30% H2O2 (10 mL) to the DAB solution, mix quickly and use immediately.
[0092] Periodic monitoring of the attenuation trend of the scattering signal of the DAB dyeing solution and observation of the dyeing test results, determination of △S.
[0093] Add 30% H2O2 (10 mL) to the newly prepared DAB solution, mix quickly, and then add Figure 1 In the structure shown, the scattering value is detected and S0:239 is obtained as follows:
[0094] 1. Start high-frequency vibration, mix the DAB staining solution and keep it still for more than 10 seconds;
[0095] 2. Start optical detection, detect the scattered signal, and detect the light intensity of the scattered light.
[0096] Use the freshly prepared DAB staining solution to perform immunohistochemical staining and observe the staining effect.
[0097] Continue to prepare 6 new DAB solutions, and detect the scattering value 0.5 hour, 1 hour, 1.5 hours, 2 hours, 2.5 hours, and 3 hours after adding 30% H2O2 (10 mL), and use them immediately for immunohistochemical staining.
[0098] The scattering values are: 367 412 535 603 698
[0104] Observe the staining effect, and have clinical film reading technical experts evaluate the films to judge the acceptability of DAB staining intensity and impurity particles after several staining films, requiring high staining intensity and low impurity particles.
[0105] According to the observation results, it is believed that the scattering value corresponding to 1.5 hours meets the requirements, while that after 1.5 does not meet the requirements.
[0106] Select 535-239=296 as △S.
[0107] The dyeing test process is as follows.
[0108] 1. Preparation
[0109] Specimen preparation:
[0110] Tissue section samples with positive KI-67 expression were selected.
[0111] Routine specimen pretreatment is performed, including sampling, fixation, slicing and other steps, to ensure specimen quality.
[0112] Reagent preparation:
[0113] Prepare the necessary reagents, such as xylene, different concentrations of ethanol (100%, 95%, 75%), PBS, 3% H2O2, antigen retrieval solution (such as 0.01M citrate buffer), 5% BSA blocking solution, KI-67 specific primary antibody, secondary antibody, DAB color development solution, hematoxylin, etc.
[0114] 2. Staining steps
[0115] Deparaffinization and hydration:
[0116] Dewax the tissue sections in xylene for three rounds, 10 min each.
[0117] Then, the mice were placed in 100% ethanol for two rounds, each for 5 minutes; 95% ethanol for two rounds, each for 5 minutes; and 75% ethanol for two rounds, each for 5 minutes.
[0118] Finally, rinse with tap water for 10 minutes.
[0119] Antigen retrieval:
[0120] Place the sections in EDTA antigen retrieval solution, making sure the sections are completely immersed.
[0121] Heat the antigen retrieval solution to boiling and keep it at a slight boil for 10 to 15 minutes.
[0122] The sections were then allowed to cool naturally to room temperature or accelerated in a cold water bath.
[0123] Wash three times with PBS with shaking for 5 minutes.
[0124] Blocking endogenous enzymes:
[0125] 3% H2O2 was added dropwise to cover the tissue sections and incubated for 20 minutes to inactivate endogenous enzymes.
[0126] This was followed by three washes with PBS for 5 minutes with shaking.
[0127] Blocking non-specific sites:
[0128] Add 5% BSA blocking solution dropwise and leave at room temperature for 30 minutes.
[0129] Shake off liquid without washing.
[0130] Add primary antibody:
[0131] Add diluted KI-67-specific primary antibody (100-300 μl) and incubate overnight at 4°C.
[0132] washing:
[0133] The next day, wash three times with PBS for 5 minutes with shaking.
[0134] Add secondary antibody:
[0135] Add secondary antibody and incubate at 37°C for 30 minutes.
[0136] This was followed by three washes with PBS for 5 minutes with shaking.
[0137] DAB color development:
[0138] DAB color developing solution (100 μL) was added dropwise, color was developed at room temperature, and the reaction time was controlled under a microscope, generally within 15 minutes.
[0139] Rinse with tap water to terminate the reaction, and then rinse with double distilled water for 2 minutes, twice in total.
[0140] Counterstaining:
[0141] Hematoxylin (100 μl) was added dropwise for light counterstaining for 40 seconds.
[0142] The reaction was terminated by rinsing with tap water and then with double distilled water for 2 minutes, twice in total.
[0143] Dehydration and transparency:
[0144] Dehydrate in 75% ethanol, 95% ethanol, and 100% ethanol, one minute per step.
[0145] Then clear through xylene, two rounds of 1 min each.
[0146] Covering:
[0147] After natural drying, the sections were sealed with neutral resin and coverslip.
[0148] To detect scattered light, the photodiode is placed at a position where the light source coaxial line deviates to detect scattered light. After preparing the dye, when it is necessary to monitor whether the dye has deteriorated, the light intensity of the scattered light is detected. When the light intensity exceeds the standard value, it is considered that deterioration has occurred and the dyeing machine needs to be re-prepared; when it does not exceed the scattering standard, it is considered that the dye has not deteriorated and can continue to be used.
[0149] When this mechanism for monitoring the degree of deterioration of DAB immunohistochemical staining solution is used, the main phenomenon that occurs during the deterioration of DAB (diaminobenzidine) stain is precipitation. The precipitation in the uniform solution will absorb and scatter the light irradiated into the solution. By irradiating the stain with a light source and monitoring the emitted light at the other end of the light source relative to the solution, the degree of precipitation can be monitored. The more precipitation, the more serious the deterioration.
[0150] The above are preferred embodiments of the present invention, which do not limit the protection scope of the present invention. Any modifications and improvements made by those skilled in the art based on the design ideas of the present invention should be regarded as within the protection scope of the present invention.
Claims
1. A mechanism for monitoring the degree of deterioration of a DAB immunohistochemical staining solution, comprising a DAB staining solution preparation container (3), characterized in that: A light source (1) is provided on one side of the DAB dye solution preparation container (3), and a mixing device (4) is provided below the DAB dye solution preparation container (3) for vibrating the solution; a scattered light monitoring device (5) for the emitted light is provided on the other side of the DAB dye solution preparation container (3).
2. The mechanism for monitoring the degree of deterioration of DAB immunohistochemical staining solution according to claim 1, characterized in that: The light source (1) is a laser light source or a combination of an LED light source and a convex lens.
3. The mechanism for monitoring the degree of deterioration of DAB immunohistochemical staining solution according to claim 1, characterized in that: The light source (1) comprises: The first socket (6), the voltage stabilizing chip (7) and the output voltage (8) provide a stable power supply for the light source (1) to ensure a balanced supply voltage; A laser (9), a variable resistor RP1 (11) for balancing the voltage inside the laser, a first transistor Q1 (12) and a second transistor Q2 (10) for providing a driving current for the laser (9); The scattered light monitoring device (5) comprises: A second socket (13) for providing power and a supply voltage (14) for providing a filtered stable voltage; The current-to-voltage converter (15), the voltage follower (16) and the analog-to-digital converter (17) amplify and convert the current into a voltage, and convert the voltage into a digital signal for output.
4. The mechanism for monitoring the degree of deterioration of DAB immunohistochemical staining solution according to claim 1, characterized in that: The mixing device (4) is fixed on a fixing seat (2) with a rubber fixing column, and the mixing device (4) is a high-frequency vibration DC vibration flat motor.
5. The mechanism for monitoring the degree of deterioration of DAB immunohistochemical staining solution according to claim 1, characterized in that: The DAB dye solution preparation container (3) is made of organic glass.
6. The method for monitoring the degree of deterioration of DAB immunohistochemical staining solution according to claim 1, characterized in that: The following steps are involved: Step 1, prepare DAB staining solution, which includes: DAB concentrate - color developing solution A, DAB diluent - containing H2O2, color developing solution B and color developing solution A at a ratio of 1:20, and mix well; Step 2, start the light source so that the light is focused on the center of the DAB dye solution preparation container (3); Step 3: Start high-frequency vibration, mix the DAB staining solution and keep it still for more than 10 seconds; Step 4, starting optical detection, monitoring the scattered signal, and detecting the light value of the scattered light; In step four, The laboratory established a standard value S0 for the scattering signal of fresh DAB staining solution; Establish the scattering signal change △S of the DAB dye solution just after deterioration; During the operation of the instrument, when a new round of experiments is carried out, the scattering signal S1 of the DAB dye solution is monitored in advance, and S0 is subtracted from S1 to obtain △S1; When △S1 is greater than △S, the staining solution is considered to have deteriorated, and the instrument drains the deteriorated staining solution in the container and re-prepares fresh DAB staining solution online; When △S1 is less than △S, the dyeing solution is considered to be not deteriorated and the current round of tests can continue to be used. When a new round of experiments is about to begin, the prepared DAB staining solution can be tested again to see if it has deteriorated.
